Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 7.23% is in line with its 5-year average of 7.72%, near the low end of its 5-year range (6.87%–9.16%).
1.00% above its 12-month average of 7.16%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.18%.
EBITDA MARGIN
7.23%
EBITDA MARGIN AVG TTM
7.16%
EBITDA MARGIN AVG 3Y
7.51%
EBITDA MARGIN AVG 5Y
7.72%
EBITDA MARGIN AVG 10Y
6.54%
EBITDA MARGIN AVG 15Y
5.36%
EBITDA MARGIN AVG 20Y
4.46%
CURRENT VS TTM AVG
+1.00%
CURRENT VS 3Y AVG
-3.73%
CURRENT VS 5Y AVG
-6.32%
CURRENT VS 10Y AVG
+10.58%
CURRENT VS 15Y AVG
+34.94%
CURRENT VS 20Y AVG
+62.23%
Option Care Health, Inc.
Market Cap
$4.65B
EBITDA Margin
7.23%
TTM Avg
7.16%
3Y Avg
7.51%
5Y Avg
7.72%
Market Cap
$4.68B
EBITDA Margin
5.54%
TTM Avg
4.34%
3Y Avg
-4.50%
5Y Avg
-6.75%
Market Cap
$4.68B
EBITDA Margin
9.15%
TTM Avg
-7.04%
3Y Avg
-33.99%
5Y Avg
-33.99%
Market Cap
$4.73B
EBITDA Margin
-8718.32%
TTM Avg
-5172.73%
3Y Avg
-3124.55%
5Y Avg
-2649.58%
Market Cap
$4.80B
EBITDA Margin
0.40%
TTM Avg
-9.29%
3Y Avg
-59.36%
5Y Avg
-227.69%
Market Cap
$4.81B
EBITDA Margin
-30.33%
TTM Avg
-1782.03%
3Y Avg
-5492.00%
5Y Avg
-5492.00%
Market Cap
$4.45B
EBITDA Margin
-31.52%
TTM Avg
-36.86%
3Y Avg
-49.55%
5Y Avg
-49.55%
Market Cap
$4.44B
EBITDA Margin
23.00%
TTM Avg
14.06%
3Y Avg
2.00%
5Y Avg
2.94%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Option Care Health, Inc. (OPCH) | $4.65B | 7.23% | 7.16% | 7.51% | 7.72% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 5.54% | 4.34% | -4.50% | -6.75% |
| BillionToOne, Inc. (BLLN)vs › | $4.68B | 9.15% | -7.04% | -33.99% | -33.99% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.73B | -8718.32% | -5172.73% | -3124.55% | -2649.58% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.80B | 0.40% | -9.29% | -59.36% | -227.69% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.81B | -30.33% | -1782.03% | -5492.00% | -5492.00% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.45B | -31.52% | -36.86% | -49.55% | -49.55% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | 23.00% | 14.06% | 2.00% | 2.94% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | -14.19% | -47.13% | -77.82% | -97.39% |
Gross Margin
18.2%
EBITDA Margin
7.2%
Operating Margin
5.9%
Net Margin
3.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 7.18% |
| 2026-03-31 | 6.87% |
| 2025-12-31 | 7.63% |
| 2025-09-30 | 7.08% |
| 2025-06-30 | 7.04% |
| 2025-03-31 | 7.17% |
| 2024-12-31 | 7.76% |
| 2024-09-30 | 7.85% |
| 2024-06-30 | 7.84% |
| 2024-03-31 | 7.36% |
| 2023-12-31 | 8.92% |
| 2023-09-30 | 8.84% |
| 2023-06-30 | 9.16% |
| 2023-03-31 | 8.06% |
| 2022-12-31 | 8.17% |
| 2022-09-30 | 7.56% |
| 2022-06-30 | 7.78% |
| 2022-03-31 | 7.45% |
| 2021-12-31 | 8.28% |
| 2021-09-30 | 7.85% |
| 2021-06-30 | 7.68% |
| 2021-03-31 | 6.17% |
| 2020-12-31 | 7.73% |
| 2020-09-30 | 6.75% |
| 2020-06-30 | 5.83% |
| 2020-03-31 | 4.32% |
| 2019-12-31 | 4.60% |
| 2019-09-30 | 2.45% |
| 2019-06-30 | -3.43% |
| 2019-03-31 | 3.40% |
| 2018-12-31 | 5.72% |
| 2018-09-30 | 8.41% |
| 2018-06-30 | 5.78% |
| 2018-03-31 | 1.90% |
| 2017-12-31 | 8.77% |
| 2017-09-30 | 6.53% |
| 2017-06-30 | 4.52% |
| 2017-03-31 | 4.39% |
| 2016-12-31 | 4.55% |
| 2016-09-30 | 3.79% |
| 2016-06-30 | 2.39% |
| 2016-03-31 | 1.37% |
| 2015-12-31 | -0.17% |
| 2015-09-30 | -5.58% |
| 2015-06-30 | -100.35% |
| 2015-03-31 | -0.17% |
| 2014-12-31 | 2.09% |
| 2014-09-30 | -9.45% |
| 2014-06-30 | -0.34% |
| 2014-03-31 | -2.39% |
| 2013-12-31 | 5.69% |
| 2013-09-30 | 1.86% |
| 2013-06-30 | 0.93% |
| 2013-03-31 | 1.28% |
| 2012-12-31 | 13.49% |
| 2012-09-30 | 3.88% |
| 2012-06-30 | 3.62% |
| 2012-03-31 | 4.40% |
| 2011-12-31 | 3.91% |
| 2011-09-30 | 7.90% |
| 2011-06-30 | 5.31% |
| 2011-03-31 | 9.62% |
| 2010-12-31 | 0.07% |
| 2010-09-30 | 3.61% |
| 2010-06-30 | 4.06% |
| 2010-03-31 | 2.32% |
| 2009-12-31 | 0.23% |
| 2009-09-30 | 2.40% |
| 2009-06-30 | 1.92% |
| 2009-03-31 | 1.66% |
| 2008-12-31 | 21.51% |
| 2008-09-30 | 1.23% |
| 2008-06-30 | 1.40% |
| 2008-03-31 | 0.53% |
| 2007-12-31 | 1.50% |
| 2007-09-30 | 1.58% |
| 2007-06-30 | 1.36% |
| 2007-03-31 | 0.89% |
| 2006-12-31 | 1.77% |
| 2006-09-30 | 2.38% |
| 2006-06-30 | 3.92% |
| 2006-03-31 | 1.43% |
| 2005-12-31 | 18.25% |
| 2005-09-30 | 1.45% |
| 2005-06-30 | 2.97% |
| 2005-03-31 | 2.34% |
| 2004-12-31 | 1.92% |
| 2004-09-30 | 2.70% |
| 2004-06-30 | 3.07% |
| 2004-03-31 | 3.39% |
| 2003-12-31 | 2.11% |
| 2003-09-30 | 2.74% |
| 2003-06-30 | 4.58% |
| 2003-03-31 | 4.51% |
| 2002-12-31 | 4.74% |
| 2002-09-30 | 5.26% |
